Status
N/A
not available
Share
Funding data (31 January 2020)
Raised
EUR
766,042.00
Min. Goal
EUR
500,000.00
Details
Country
Finland
Sector
HealthcareBiotechnology
End date
31 January 2020
(2398 days)
Description
“Askel offers a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a medical device already on the 250M€ market for animal health with excellent clinical results. The next step is to enter into the 2.2B$ human market.”